Kangji Medical Completes its Listing on HKEx
2020-06-30

June 29th, Kangji Medical was listed in Hong Kong, with about HK $ 3.13 billion has been raised.

 

Goldman Sachs, CITIC Securities and BofA Securities were joint sponsors in the deal.

 

Sidley Austin, Tian Yuan Law Firm and Maples and Calder (Hong Kong) LLP were legal advisors to issuer on Hong Kong and United States laws, PRC laws and Cayman Islands laws respectively.

 

Sullivan & Cromwell (Hong Kong) LLP, King & Wood Mallesons were legal advisors to sole sponsor on Hong Kong and United States laws and PRC laws respectively.

 

Ernst & Young was the reporting accountants and independent auditor in the deal.

 

Founded in 2004 in Hangzhou, Kangji Medical is the largest domestic minimally invasive surgical instruments and accessories developer and manufacturer in China.

 

This is the largest IPO to date in 2020 of the medical instrument industry in Hong Kong.